Vivos Inc. (OTCMKTS:RDGL – Get Free Report)’s share price fell 0.2% on Wednesday . The stock traded as low as $0.13 and last traded at $0.13. 478,156 shares changed hands during trading, a decline of 48% from the average session volume of 923,381 shares. The stock had previously closed at $0.13.
Vivos Stock Performance
The company has a market cap of $58.82 million, a PE ratio of -12.97 and a beta of 1.06. The business’s 50-day moving average is $0.12 and its 200 day moving average is $0.12.
Vivos Company Profile
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
See Also
- Five stocks we like better than Vivos
- Asset Allocation Strategies in Volatile Markets
- Intuit’s AI Boom: Stock Soaring, But Should Investors Hit Pause?
- Consumer Staples Stocks, Explained
- Top Dividend Plays With Strong Analyst Ratings
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Robinhood Stock Keeps Giving Investors Reasons To Buy
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
